Exploring the Vaccine Adjuvant Effect and Mechanism of Epimedium Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations
Vaccines · 26.04.2026 · 14 (5) · 385
DOI: 10.3390/vaccines14050385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 26.04.2026. Verfasst von Meng Tang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, China. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major project, Special Project for improving the scientific research and innovation of Third Military Medical University.
Abstract (Originalsprache)
Background
Epimedium is a natural herb with immunomodulatory potential, but its vaccine adjuvant properties remain poorly understood.
Objective
The aim of this study was to elucidate the adjuvant effects of Epimedium and the underlying molecular mechanisms.
Methods
Network pharmacology was used to identify bioactive compounds and targets of Epimedium from the TCMSP database, and immunomodulation-related targets from GeneCards and OMIM. PPI networks, KEGG/GO enrichment, molecular docking, and molecular dynamics (MD) simulations were performed. In vivo, female BALB/c mice were immunized with the Staphylococcus aureus (S. aureus) vaccine subunit HI antigen, either alone or with low- or high-dose icariin (ICA). Serum antibody responses (IgG, IgG1, IgG2a, IgG2b) were measured by ELISA. Survival against lethal S. aureus USA300 challenge was monitored.
Results
Network pharmacology predicted 488 targets and 13 pathways. Core targets included IL6, TP53, EGFR, CTNNB1, HIF1A, HSP90AA1, JUN, MTOR, SRC, and AKT1. KEGG/GO analysis indicated involvement of T cell receptor and NOD-like receptor signaling pathways in inflammatory responses. Molecular docking and MD simulations confirmed stable ligand-target binding. Experimental validation showed that ICA significantly enhanced HI-specific antibody responses and induced a Th2-biased humoral immune response (IgG1/IgG2a ratio > 1), which is particularly relevant for vaccines targeting extracellular pathogens such as S. aureus. ICA also improved survival after lethal bacterial challenge.
Conclusions
This study identifies potential bioactive compounds, core targets, and key pathways of Epimedium as a vaccine adjuvant. Experimentally, ICA, as a representative component, enhanced HI-specific antibody responses and conferred protection against lethal S. aureus challenge. Together, these findings offer a computational–experimental basis that may guide further mechanistic investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
- State Key Laboratory of Trauma, Burn and Combined Injury, Third Military Medical University, Chongqing 400038, China.
ORCID-Profile: Hongwu Sun
Förderung
- Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major project
- Special Project for improving the scientific research and innovation of Third Military Medical University
Zitieren
APA
Tang, M., Zhao, A., Yang, Y., Song, Z., Wang, S., Ye, X., Luo, H., Zhao, L., Pan, J., Zou, Q., Sun, H., & Zeng, H. (2026). Exploring the Vaccine Adjuvant Effect and Mechanism of Epimedium Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations. Vaccines, 14(5), 385. https://doi.org/10.3390/vaccines14050385
Vancouver
Tang M, Zhao A, Yang Y, Song Z, Wang S, Ye X, et al. Exploring the Vaccine Adjuvant Effect and Mechanism of Epimedium Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations. Vaccines. 2026;14(5):385. doi:10.3390/vaccines14050385
BibTeX
@article{Tang2026,
author = {Tang, Meng and Zhao, Anni and Yang, Yun and Song, Zhen and Wang, Sheng and Ye, Xianghao and Luo, Haozheng and Zhao, Liqun and Pan, Jiale and Zou, Quanming and Sun, Hongwu and Zeng, Hao},
title = {Exploring the Vaccine Adjuvant Effect and Mechanism of Epimedium Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {5},
pages = {385},
doi = {10.3390/vaccines14050385}
}
EUVIMED